Prognostic significance of combined conventional and immunocytochemical cytology for peritoneal washings in endometrial carcinoma

This publication has 19 references indexed in Scilit:

• p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer
  Gynecologic Oncology, 1999
• Prognostic Significance of Angiogenesis and Ki-67, p53, and p21 Expression: A Population-Based Endometrial Carcinoma Study
  Journal of Clinical Oncology, 1999
• Role of Immunohistochemistry in Distinguishing Epithelial Peritoneal Mesotheliomas From Peritoneal and Ovarian Serous Carcinomas
  The American Journal of Surgical Pathology, 1998
• p53 Gene Product in Pleural Effusions
  Acta Cytologica, 1996
• Cell transfer technique with Malinol mounting medium. An application to immunocytochemistory and ISH methods.
  The Journal of the Japanese Society of Clinical Cytology, 1996
• Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease
  Gynecologic Oncology, 1992
• Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
  Gynecologic Oncology, 1991
• Prognostic value of peritoneal cytology in endometrial carcinoma
  Gynecologic Oncology, 1990
• Malignant Peritoneal Cytology as Prognostic Indicator in Stage I Endometrial Cancer
  Obstetrics & Gynecology, 1983
• The prognostic value of peritoneal cytology in gynecologic malignant disease
  American Journal of Obstetrics and Gynecology, 1971